Further analysis across GSE178631, GSE169038, GSE134160, GSE21034, and GSE77930 revealed significant upregulation of TMSB10 in high ISUP grade and advanced T-stage prostate cancers, as well as metastatic cases. Here, TMSB10 is linked to prostate carcinoma.